Showing 11,721 - 11,740 results of 21,572 for search '(( 50 ((ng decrease) OR (((we decrease) OR (mean decrease)))) ) OR ( 50 c decrease ))', query time: 0.86s Refine Results
  1. 11721

    EGC inhibits breast cancer growth and LDH-A expression <i>in vivo</i>. by Zhiyu Wang (282312)

    Published 2013
    “…The results showed that in both breast cancer xenografts, the expression levels of LDH-A, Ki67 and HIF-1α were decreased in comparison to that in control groups, while apoptosis ratio was elevated in EGC-treated tumor samples detected by TUNEL method; (C) Western blotting analysis showed that the expression of HIF-1α and LDH-A in EGC-treated tumor samples were significantly decreased in comparison with control groups (left panel). …”
  2. 11722

    Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes by Xing Ji (3096735)

    Published 2025
    “…Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”
  3. 11723
  4. 11724

    Table_2_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  5. 11725

    Table_6_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  6. 11726

    Table_1_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  7. 11727

    Table_5_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  8. 11728

    Table_3_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  9. 11729

    Table_4_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOCX by Guangzhi Hao (13836529)

    Published 2022
    “…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
  10. 11730
  11. 11731
  12. 11732
  13. 11733
  14. 11734

    Therapeutic efficacy study in <i>E</i>. <i>granulosus</i> infected mice. by Julia A. Loos (737868)

    Published 2017
    “…<p>(A) Box plots showing the comparative distribution of the weight (g) of cysts recovered from untreated mice (C) and treated with albendazole (ABZ, 5 mg/kg/d), metformin (Met, 50 mg/kg/d) and the combination of both drugs (ABZ+Met) for 60 days. …”
  15. 11735
  16. 11736

    Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis? by Felice Amato (394509)

    Published 2013
    “…The expression analysis demonstrated that the c.*1043A>C increases the affinity for miR-509-3p and slightly decreases that for the miR-433. …”
  17. 11737

    Presentation_1_CRISPR/Cas9-Targeted Mutagenesis of BnaFAE1 Genes Confers Low-Erucic Acid in Brassica napus.PPTX by Yunhao Liu (3434894)

    Published 2022
    “…There are two functional homologous copies of FAE1 on the A08 and C03 chromosomes in B. napus. In this study, we used CRISPR/Cas9 technology to create targeted mutations on these two homologous copies of BnaFAE1 in three B. napus germplasms with high EA (>30%) and high oil (>50%). …”
  18. 11738

    Table_1_CRISPR/Cas9-Targeted Mutagenesis of BnaFAE1 Genes Confers Low-Erucic Acid in Brassica napus.XLSX by Yunhao Liu (3434894)

    Published 2022
    “…There are two functional homologous copies of FAE1 on the A08 and C03 chromosomes in B. napus. In this study, we used CRISPR/Cas9 technology to create targeted mutations on these two homologous copies of BnaFAE1 in three B. napus germplasms with high EA (>30%) and high oil (>50%). …”
  19. 11739

    Clinical and virological profiles of EVN<sub>Term</sub> challenged vaccinated and naïve ponies. by Jodi K. Craigo (421284)

    Published 2013
    “…Febrile episodes were defined by a achieving a combination of two-three features such as: rectal temperature above 39°C in conjunction with thrombocytopenia (platelet decrease of ≥70,000/µl of whole blood), EIAV viral load ≥10<sup>5</sup> as well as other clinical signs of EIA.…”
  20. 11740

    Low- and High-Volume of Intensive Endurance Training Significantly Improves Maximal Oxygen Uptake after 10-Weeks of Training in Healthy Men by Arnt Erik Tjønna (416233)

    Published 2013
    “…A growing body of evidence suggests that exercise training with low-volume but high-intensity may be a time-efficient means to achieve health benefits. In the present study, we measured changes in VO<sub>2max</sub> and traditional cardiovascular risk factors after a 10 wk. training protocol that involved three weekly high-intensity interval sessions. …”